Digest Network Come funziona
Network
/
Società
Li
Non verificato

Ligand Pharmaceuticals Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaFinanzaMedicina - VarieSalute

13 comunicati stampa

Guarda tutti i comunicati
13/02/2025
Biotecnologia
Finanza
Salute
Associazioni/Professionisti
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/02/2025
Associazioni/Professionisti
Salute
Finanza
Medicina - Varie
Farmaceutica
Biotecnologia
Eventi
Fiere
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
10/12/2024
Web e Social Network
Eventi
Industria
Associazioni/Professionisti
Salute
Finanza
Medicina - Varie
Farmaceutica
Biotecnologia
Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
14/11/2024
Eventi
Biotecnologia
Farmaceutica
Salute
Ligand to Present at Stifel 2024 Healthcare Conference
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
07/11/2024
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
01/11/2024
Eventi
Comunicazione
Salute
Sanità
Farmaceutica
Biotecnologia
Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
23/10/2024
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/09/2024
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
20/08/2024
Biotecnologia
Farmaceutica
Salute
Eventi
Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
06/08/2024
Biotecnologia
Farmaceutica
Salute
Oncologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Ligand Reports Second Quarter 2024 Financial Results
Fonte
Ligand Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0